secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001809519-26-000110
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx Q1 revenue $194M, raises FY2026 guidance; Pharma Direct up 82% YoY
-------------------------------------------------------------------------

- Revenue $194.0M; net income $1.2M; adjusted EBITDA $58.3M (30.0% margin).
- Pharma Direct Revenue increased 82% YoY, leading growth momentum.
- Company raises full year 2026 revenue and adjusted EBITDA expectations.
- Adjusted Net Income $23.0M; Adjusted Net Income Margin 11.9%.
- Net cash from operating activities $11.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000110/0001809519-26-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000110/gdrx-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001809519-26-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer